Fecal Microbiota Transplantation and Successful Resolution of Multidrug-Resistant-Organism Colonization
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
We report a case in which fecal microbiota transplantation (FMT) utilized for relapsing Clostridium difficile colitis successfully eradicated colonization with several multidrug-resistant organisms (MDROs). FMT may have an additive benefit of reducing MDRO carriage and should be further investigated as a potential measure to eradicate additional potentially virulent organisms beyond C. difficile.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several case reports and animal models have also revealed the probable therapeutic effects of FMT in patients with severe multiple sclerosis, 41 autism, 42 multidrug-resistant organisms (MDRO) infections, 43 and multiple organ dysfunction in critical patients.44”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [43]
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 1×
“difficile infections based on case series (3, 4) and, more recently, on a randomized clinical trial (5).”
BackgroundControl of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625 · cited 2×
“The intact human microbiome is a primary host defense for the prevention of the colonization, dominance, and infection of pathogens and pathobionts (6).”
BackgroundMicrobiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564 · cited 1×
“difficile—repopulation with normal intestinal microbiota together with subsequent out-competition of MDROs (7).”
BackgroundTaur, Y., Xavier, J. B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., Lee, Y. J., Dubin, K. A., Socci, N. D., Viale, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis580 · Cited by 1,020 · cited 1×
“Prior studies have shown that the dominance of pathogenic Gram-negative bacteria and enterococcus in the gastrointestinal tract often precedes colonization at other body sites and subsequent infections, especially among critically ill patients (8, 9).”
BackgroundGough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
(1958) · PubMed · Cited by 978
Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., Viale, A., Socci, N. D., van den Brink, M. R. M., Kamboj, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43918 · Cited by 943 · cited 2×
“Since our patient received standard clinical care and treatment, it is difficult to estimate the precise effect of FMT; however, there was a notable temporal decline in MDRO colonization and infections, and studies have shown that decolonization often prevents future infections (9).”
BackgroundKassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Mutation Frequencies and Antibiotic Resistance
Martinez, J. L., & Baquero, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1771-1777.2000 · Cited by 694
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Research works printed but not linked: 1
- Freedman A, Eppes S. 2014. Use of stool transplantation to clear fecal colonization with carbapenem-resistant Enterobacteriaceae (CRE): proof of concept, abstr 1805. Abstr Soc Healthcare Epidemiol AM (SHEA) IDWeek 2014, 11 October 2014, Philadelphia, PA.
Cited by
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E. A., Liu, E., Cox, I. J., Kheradman, R., Heuman, D., Wang, J., Gurry, T., et al. (2017) · Hepatology · doi:10.1002/hep.29306 · Cited by 633
Fecal microbiota transplantation: Review and update
Wang, J.-W., Kuo, C.-H., Kuo, F.-C., Wang, Y.-K., Hsu, W.-H., Yu, F.-J., Hu, H.-M., Hsu, P.-I., Wang, J.-Y., & Wu, D.-C. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.08.011 · Cited by 576
How Probiotics Affect the Microbiota
Wieërs, G., Belkhir, L., Enaud, R., Leclercq, S., Philippart de Foy, J.-M., Dequenne, I., de Timary, P., & Cani, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00454 · Cited by 525
Fernández, J., Prado, V., Trebicka, J., Amoros, A., Gustot, T., Wiest, R., Deulofeu, C., Garcia, E., Acevedo, J., Fuhrmann, V., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.027 · Cited by 374
Tacconelli, E., Mazzaferri, F., de Smet, A. M., Bragantini, D., Eggimann, P., Huttner, B. D., Kuijper, E. J., Lucet, J.-C., Mutters, N. T., Sanguinetti, M., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.01.005 · Cited by 236
Millan, B., Park, H., Hotte, N., Mathieu, O., Burguiere, P., Tompkins, T. A., Kao, D., & Madsen, K. L. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw185 · Cited by 220
Antibiotic prophylaxis in cirrhosis: Good and bad
Fernández, J., Tandon, P., Mensa, J., & Garcia‐Tsao, G. (2016) · Hepatology · doi:10.1002/hep.28330 · Cited by 203
The challenges of multi-drug-resistance in hepatology
Fernández, J., Bert, F., & Nicolas-Chanoine, M.-H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.006 · Cited by 187
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge
Fernández, J., Piano, S., Bartoletti, M., & Wey, E. Q. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.010 · Cited by 161
Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review
Woodworth, M. H., Carpentieri, C., Sitchenko, K. L., & Kraft, C. S. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1286006 · Cited by 149
Davidovics, Z. H., Michail, S., Nicholson, M. R., Kociolek, L. K., Pai, N., Hansen, R., Schwerd, T., Maspons, A., Shamir, R., Szajewska, H., et al. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002205 · Cited by 126
Saha, S., Tariq, R., Tosh, P. K., Pardi, D. S., & Khanna, S. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.006 · Cited by 134
Battipaglia, G., Malard, F., Rubio, M. T., Ruggeri, A., Mamez, A. C., Brissot, E., Giannotti, F., Dulery, R., Joly, A. C., Baylatry, M. T., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.198549 · Cited by 129
Wang, Y., Zhang, S., Borody, T. J., & Zhang, F. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002339 · Cited by 120
Manges, A. R., Steiner, T. S., & Wright, A. J. (2016) · Infectious Diseases · doi:10.1080/23744235.2016.1177199 · Cited by 117
Microbiome as a tool and a target in the effort to address antimicrobial resistance
Relman, D. A., & Lipsitch, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717163115 · Cited by 113
Intestinal microbiota and antibiotic resistance: Perspectives and solutions
Casals‐Pascual, C., Vergara, A., & Vilà, J. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.05.002 · Cited by 106
Gargiullo, L., CHIERICO, F. D., D’Argenio, P., & Putignani, L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01704 · Cited by 89
Enlisting commensal microbes to resist antibiotic-resistant pathogens
Keith, J. W., & Pamer, E. G. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180399 · Cited by 87
The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms
Porreca, A. M., Sullivan, K. V., & Gallagher, J. C. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0617-x · Cited by 86
Ghani, R., Mullish, B. H., McDonald, J. A. K., Ghazy, A., Williams, H. R. T., Brannigan, E., Mookerjee, S., Satta, G., Gilchrist, M. J., Duncan, N. D., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa948 · Cited by 83
Woodworth, M. H., Hayden, M. K., Young, V. B., & Kwon, J. H. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz288 · Cited by 80
Matzaras, R., Nikopoulou, A., Protonotariou, E., & Christaki, E. (2022) · PubMed Central · Cited by 77
Biliński, J., Grzesiowski, P., Muszyński, J., Wróblewska, M., Mądry, K., Robak, K., Dzieciątkowski, T., Wiktor-Jędrzejczak, W., & Basak, G. W. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0387-9 · Cited by 77
Dubberke, E. R., Mullane, K. M., Gerding, D. N., Lee, C. H., Louie, T. J., Guthertz, H., & Jones, C. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw133 · Cited by 75
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature
Cohen, N. A., & Maharshak, N. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4535-9 · Cited by 71
The gut microbiota in transplant patients
Chong, P. P., & Koh, A. Y. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100614 · Cited by 58
Goldenberg, S. D., Batra, R., Beales, I., Digby-Bell, J. L., Irving, P. M., Kellingray, L., Narbad, A., & Franslem-Elumogo, N. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0189-y · Cited by 56
Kelly, B. J., & Tebas, P. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.09.002 · Cited by 54
The concept of probiotics, prebiotics, postbiotics, synbiotics, nutribiotics, and pharmabiotics
Chaudhari, A., & Dwivedi, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823733-5.00013-1 · Cited by 54
Microbiota-Based Therapies for Clostridium difficile and Antibiotic-Resistant Enteric Infections
Lewis, B. B., & Pamer, E. G. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093549 · Cited by 51
Improving Risk–Benefit in Faecal Transplantation through Microbiome Screening
Papanicolas, L. E., Gordon, D., Wesselingh, S. L., & Rogers, G. B. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2019.12.009 · Cited by 49
Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead
Borody, T. J., Fischer, M., Mitchell, S., & Campbell, J. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1086267 · Cited by 47
Stalenhoef, J. E., Terveer, E. M., Knetsch, C. W., Hof, P. V. ‘., Vlasveld, I. N., Keller, J. J., Visser, L. G., & Kuijper, E. J. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx047 · Cited by 47
Huang, Y., Lai, L., Chen, Y., Lin, K., Chou, Y.-H., Chen, H.-C., Wang, S., Wang, J., & Chang, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01402 · Cited by 47
Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms
Araos, R., Tai, A., Snyder, G. M., Blaser, M. J., & D’Agata, E. M. C. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw426 · Cited by 46
Hourigan, S. K., Ahn, M., Gibson, K. M., Pérez-Losada, M., Felix, G., Weidner, M., Leibowitz, I., Niederhuber, J. E., Sears, C. L., Crandall, K. A., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz379 · Cited by 43
Yoon, Y. K., Suh, J. W., Kang, E.-J., & Kim, J. Y. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1662477 · Cited by 46
Aira, A., Fehér, C., Rubio-García, E., & Soriano, À. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-00272-7 · Cited by 45
Bacteriotherapy for inflammatory bowel disease
Yoshimatsu, Y., Mikami, Y., & Kanai∥, T. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-020-00153-4 · Cited by 44
Ghani, R., Mullish, B. H., Roberts, L. A., Davies, F., & Marchesi, J. R. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2038856 · Cited by 44
Nooij, S., Vendrik, K. E. W., Zwittink, R. D., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., Terveer, E. M., & on behalf of the Netherlands Donor Feces Bank study group (2024) · Genome Medicine · doi:10.1186/s13073-024-01306-7 · Cited by 41
Drug-Resistant Infection: Causes, Consequences, and Responses
Jamrozik, E., & Selgelid, M. J. (2020) · Public health ethics analysis · doi:10.1007/978-3-030-27874-8_1 · Cited by 43
Combatting Antibiotic Resistance: Leveraging Fecal Microbial Transplantation for Gut Health
Upreti, P., Devhare, L., Abdulmageed, L. H., Kumar, Y. G., Kumar, R., & Dharmamoorthy, G. (2024) · Springer eBooks · doi:10.1007/978-981-97-5272-0_10 · Cited by 35
Wang, T. L., Kraft, C. S., Woodworth, M. H., Dhere, T., & Eaton, M. E. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy016 · Cited by 35
Microbial approaches for targeting antibiotic‐resistant bacteria
Wong, W. F., & Santiago, M. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12783 · Cited by 34
Galloway-Peña, J. R., Jenq, R. R., & Shelburne, S. A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3173 · Cited by 32
Human Microbiome and Its Medical Applications
Zhang, Y., Zhou, L., Xia, J., Dong, C., & Luo, X. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.703585 · Cited by 32
Fernández, S. G., Morosini, M.-I., Cobo, M., Olcina, J. R. F., López–Sanromán, A., Cobo, J., Romero, J., Cantón, R., & del Campo, R. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.09.004 · Cited by 29
Bulow, C., Langdon, A. E., Hink, T., Wallace, M. A., Reske, K. A., Patel, S., Sun, X., Seiler, S. M., Jones, S., Kwon, J. H., et al. (2018) · mSphere · doi:10.1128/mspheredirect.00588-18 · Cited by 28
Searching for superstool: maximizing the therapeutic potential of FMT
Olesen, S. W., Leier, M., Alm, E. J., & Kahn, S. A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0019-4 · Cited by 27
Gopalsamy, S. N., Woodworth, M. H., Wang, T. L., Carpentieri, C., Mehta, N., Friedman‐Moraco, R., Mehta, A. K., Larsen, C. P., & Kraft, C. S. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.08.015 · Cited by 26
The microbiome in pediatric oncology
Rotz, S. J., & Dandoy, C. E. (2020) · Cancer · doi:10.1002/cncr.33030 · Cited by 27
Su, F., Luo, Y., Yu, J., Shi, J., Zhao, Y., Yan, M., Huang, H., & Tan, Y. (2021) · European journal of medical research · doi:10.1186/s40001-021-00508-8 · Cited by 25
Beck, A. (2019) · Social & Cultural Geography · doi:10.1080/14649365.2019.1593490 · Cited by 24
Bacterial, Gut Microbiome-Modifying Therapies to Defend against Multidrug Resistant Organisms
Feehan, A. K., & Garcia‐Diaz, J. (2020) · Microorganisms · doi:10.3390/microorganisms8020166 · Cited by 23
Editorial Commentary: The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance
Halpin, A. L., & McDonald, L. C. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw187 · Cited by 23
Rauseo, A. M., Hink, T., Reske, K. A., Seiler, S. M., Bommarito, K. M., Fraser, V. J., Burnham, C. D., & Dubberke, E. R. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.94 · Cited by 21
Santiago, M., 1 Finch Therapeutics, 2. I. B. R., Eysenbach, L. M., Allegretti, J. R., Aroniadis, O. C., Brandt, L. J., Fischer, M., Grinspan, A. M., Kelly, C. R., Morrow, C. D., et al. (2019) · AIMS Microbiology · doi:10.3934/microbiol.2019.1.1 · Cited by 20
Surveillance and control of asymptomatic carriers of drug‐resistant bacteria
Jamrozik, E., & Selgelid, M. J. (2019) · Bioethics · doi:10.1111/bioe.12642 · Cited by 21
Davido, B., Batista, R., Dinh, A., TRUCHIS, P. D., Terveer, E. M., Roberts, B., Kuijper, E. J., & Caballero, S. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.03.008 · Cited by 19
Davido, B., Watson, A. R., de Truchis, P., Galazzo, G., Dinh, A., Batista, R., Terveer, E. M., Lawrence, C., Michelon, H., Jobard, M., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106216 · Cited by 18
Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles
Smibert, O. C., Satlin, M. J., Nellore, A., & Peleg, A. Y. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0679-4 · Cited by 18
Ueckermann, V., Hoosien, E., de Villiers, N., & Geldenhuys, J. (2020) · Case Reports in Infectious Diseases · doi:10.1155/2020/8462659 · Cited by 17
Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome
Gerardin, Y., Timberlake, S. C., Allegretti, J. R., Smith, M. B., & Kassam, Z. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa700 · Cited by 18
Fecal microbiota transplantation for antibiotic resistant bacteria decolonization
Amrane, S., & Lagier, J. (2020) · Human Microbiome Journal · doi:10.1016/j.humic.2020.100071 · Cited by 16
Neidhöfer, C., Berens, C., & Parčina, M. (2022) · Antibiotics · doi:10.3390/antibiotics11030311 · Cited by 16
Belga, S., Chiang, D., Kabbani, D., Abraldeṣ, J. G., & Cervera, C. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1607297 · Cited by 16
Steed, D. B., Wang, T. L., Raheja, D., Waldman, A. D., Babiker, A. Y. M., Dhere, T., Kraft, C. S., & Woodworth, M. H. (2020) · mSphere · doi:10.1128/msphere.00853-20 · Cited by 15
Woodworth, M. H., Hayden, M. K., Young, V. B., & Kwon, J. H. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz391 · Cited by 11
Microbiota transplantation and/or CRISPR/Cas in the battle against antimicrobial resistance
Vilà, J. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.03.043 · Cited by 10
Management of Multidrug-Resistant Infections in Cirrhosis
Gallaher, C., & Shawcross, D. L. (2022) · Seminars in Liver Disease · doi:10.1055/a-1765-0056 · Cited by 10
Antimicrobial resistance in liver disease: better diagnostics are needed
Shallcross, L. J., & O'Brien, A. J. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30240-0 · Cited by 10
Fecal microbiota transplantation as a potential way to eradicate multiresistant microorganisms
Dias, C., Pipa, S., Duarte-Ribeiro, F., & Mota, M. (2018) · IDCases · doi:10.1016/j.idcr.2018.e00432 · Cited by 9
Editorial Commentary: Fecal ESBL Screening: Are We Ready for This Information?
Turbett, S. E., & Mansour, M. K. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw288 · Cited by 9
Mechanisms and Therapeutic Potential of Nutritional Immunity
Ugwu, C. E., Akinsulie, O. C., Ayandokun, T. F., Ajibade, F. A., Shahzad, S., Aliyu, V. A., Oladoye, M. J., Idris, I., Obasi, K. O., Edeh, J. K., et al. (2026) · Pathogens · doi:10.3390/pathogens15020176 · Cited by 7
Xiao, P. G., Li, Y., Li, X., Ge, T., Li, D., Xu, Q., Ruan, Y., Xiao, F., Xiao, Y., & Zhang, T. (2025) · BMC Microbiology · doi:10.1186/s12866-025-03858-z · Cited by 7
Microbes as a tool to defend against antibiotic resistance in food animal production
BHUNIA, A. K. (2019) · Indian Journal of Animal Health · doi:10.36062/ijah.58.2spl.2019.01-18 · Cited by 7
Surveillance and Control of Asymptomatic Carriers of Drug-Resistant Bacteria
Jamrozik, E., & Selgelid, M. J. (2020) · Public health ethics analysis · doi:10.1007/978-3-030-27874-8_12 · Cited by 6
THE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIUM DIFFICILE INFECTION.
Edmond, M. B. (2016) · PubMed Central · Cited by 5
A formidable foe: carbapenem-resistant Acinetobacter baumannii and emerging nonantibiotic therapies
Watkins, R. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1503054 · Cited by 5
Kříž, J., Hyšperská, V., Bébrová, E., & Roznětinská, M. (2024) · Infection Prevention in Practice · doi:10.1016/j.infpip.2024.100340 · Cited by 4
Vissichelli, N. C., Barajas‐Ochoa, A., Morales, M. K., Thomas, L. D., & Pouch, S. M. (2025) · Liver Transplantation · doi:10.1097/lvt.0000000000000702 · Cited by 3
Fecal microbiota transplantation - something more than merely a therapeutic curiosity
Ferre‐Aracil, C., Aguilera, L., de Santiago, E. R., de Paredes, A. G. G., & López–Sanromán, A. (2015) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2015.3875/2015 · Cited by 3
Acute on Chronic Liver Failure: Role of the Bacterial Infections
Borzio, M., & Dionigi, E. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.93440 · Cited by 2
Faecal microbiota transplantation associated adverse events
Patryn, R. K., Kaźmierczak-Wojtaś, N., Bułaś, L., Boretska, O., Szkultecka-Dębek, M., Drozd, M., & Blicharski, T. (2024) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2024-0028 · Cited by 2
The Microbiome and Antimicrobial Stewardship in Surgical Patients
Creel, J., & Maves, R. C. (2023) · Surgical Infections · doi:10.1089/sur.2022.422 · Cited by 2
Fecal Transplant: How an Ancient Therapy Is Finding a New Use in Today’s Antibiotic-Resistant Era
McBeth, A., & Dobner, P. (2019) · Journal of Restorative Medicine · doi:10.14200/jrm.2019.0117 · Cited by 1
Silva, D. R., Sakaguchi, O. A. S., da Silva, A. C. B., Sardi, J. D. C. O., de Carvalho, R. D. P., Roque, S. M., Borges, L. P. S., Lins, R. B. E., Campos, L. T., & Costa, E. M. M. D. B. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.98865 · Cited by 1
Mansoor, A., O’Neil, C. A., & Kwon, J. H. (2023) · Anaerobe · doi:10.1016/j.anaerobe.2023.102772 · Cited by 1
Fecal Microbial Transplantation and its Expansion into the Treatment of Other Diseases
Millan, B. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3gq6r939 · Cited by 1
Quigley, E. M. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727689876.793569658 · Cited by 1
Advances in Fecal Microbiota TransplantationPreprint
Gollamudi, S. (2016) · doi:10.15200/winn.148321.15013
Grekin, J. A. (2018) · Clinical Research in Practice The Journal of Team Hippocrates · doi:10.22237/crp/1534464120
A Mechanism of Antimicrobial Resistance and a Mitigation Strategy
Bulow, C. (2018) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/5vzy-r748
Ahmed, N., & Sarker, N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734652855.793557876
Jalan, R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727689876.793573489
Pandémies et antibiorésistance: Menaces sur la santé globale au temps de l’Anthropocène
Sansonetti, P. J. (2025) · médecine/sciences · doi:10.1051/medsci/2025127
Nooij, S., Vendrik, K. E. W., Zwittink, R. D., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Terveer, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26686896
Nooij, S., Vendrik, K. E. W., Zwittink, R. D., Ducarmon, Q. R., Keller, J. J., Kuijper, E. J., & Terveer, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26686899
Metadata
- Authors
- Crum-Cianflone, N. F., Sullivan, E., & Ballon-Landa, G.
- Affiliations
- Infectious Disease Division, Scripps Mercy Hospital, San Diego, California, USA
- Scripps Mercy Hospital (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2015-06
- Volume
- 53
- Issue
- 6
- Pages
- 1986-1989
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC4432040
- OpenAlex
- W2160721831
- Cited by
- 103
- References
- 17
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 6 · 2020: 14 · 2019: 18 · 2018: 17 · 2017: 9 · 2016: 12 · 2015: 3
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- fecal microbiota transplantation, multidrug-resistant organisms, Clostridium difficile colitis, MDRO colonization, gut microbiota
- MeSH terms
- Fecal Microbiota Transplantation, Aged, Enterocolitis, Pseudomembranous, Humans, Male, Clostridioides difficile, Fatal Outcome, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.